As of 2026-04-05, the Relative Valuation of Mesa Laboratories Inc (MLAB) is 35.09 USD. This relative valuation is based on P/E multiples. With the latest stock price at 91.08 USD, the upside of Mesa Laboratories Inc based on Relative Valuation is -61.5%.
The range of the Relative Valuation is 23.00 - 50.60 USD.
| Range | Selected | |
| Trailing P/E multiples | 34.0x - 40.6x | 38.2x |
| Forward P/E multiples | 25.6x - 34.7x | 30.4x |
| Fair Price | 23.00 - 50.60 | 35.09 |
| Upside | -74.7% - -44.4% | -61.5% |
| Date | P/E |
| 2026-04-02 | 134.64 |
| 2026-04-01 | 130.77 |
| 2026-03-31 | 130.71 |
| 2026-03-30 | 125.76 |
| 2026-03-27 | 121.32 |
| 2026-03-26 | 120.85 |
| 2026-03-25 | 123.59 |
| 2026-03-24 | 119.94 |
| 2026-03-23 | 121.81 |
| 2026-03-20 | 118.26 |
| 2026-03-19 | 121.99 |
| 2026-03-18 | 118.75 |
| 2026-03-17 | 120.76 |
| 2026-03-16 | 116.76 |
| 2026-03-13 | 115.25 |
| 2026-03-12 | 115.03 |
| 2026-03-11 | 119.15 |
| 2026-03-10 | 108.26 |
| 2026-03-09 | 129.63 |
| 2026-03-06 | 128.72 |
| 2026-03-05 | 129.48 |
| 2026-03-04 | 137.23 |
| 2026-03-03 | 135.06 |
| 2026-03-02 | 137.84 |
| 2026-02-27 | 142.76 |
| 2026-02-26 | 141.27 |
| 2026-02-25 | 140.50 |
| 2026-02-24 | 140.79 |
| 2026-02-23 | 138.71 |
| 2026-02-20 | 138.02 |
| 2026-02-19 | 136.03 |
| 2026-02-18 | 138.16 |
| 2026-02-17 | 131.02 |
| 2026-02-13 | 133.92 |
| 2026-02-12 | 130.93 |
| 2026-02-11 | 134.87 |
| 2026-02-10 | 135.93 |
| 2026-02-09 | 134.25 |
| 2026-02-06 | 137.88 |
| 2026-02-05 | 134.82 |
| 2026-02-04 | 135.31 |
| 2026-02-03 | 129.40 |
| 2026-02-02 | 119.00 |
| 2026-01-30 | 116.43 |
| 2026-01-29 | 116.31 |
| 2026-01-28 | 116.70 |
| 2026-01-27 | 120.60 |
| 2026-01-26 | 120.81 |
| 2026-01-23 | 122.20 |
| 2026-01-22 | 127.77 |